BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27852165)

  • 1. Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms.
    Cagni FC; Campêlo CLDC; Coimbra DG; Barbosa MR; Júnior LGO; Neto ABS; Ribeiro AM; Júnior COG; Gomes de Andrade T; Silva RH
    J Neuropsychiatry Clin Neurosci; 2017; 29(2):142-147. PubMed ID: 27852165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF polymorphism associates with decline in set shifting in Parkinson's disease.
    van der Kolk NM; Speelman AD; van Nimwegen M; Kessels RP; IntHout J; Hakobjan M; Munneke M; Bloem BR; van de Warrenburg BP
    Neurobiol Aging; 2015 Mar; 36(3):1605.e1-6. PubMed ID: 25444596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
    Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
    J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
    Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
    Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.
    Gatt JM; Nemeroff CB; Dobson-Stone C; Paul RH; Bryant RA; Schofield PR; Gordon E; Kemp AH; Williams LM
    Mol Psychiatry; 2009 Jul; 14(7):681-95. PubMed ID: 19153574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
    Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
    Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
    Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
    Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.
    Foltynie T; Lewis SG; Goldberg TE; Blackwell AD; Kolachana BS; Weinberger DR; Robbins TW; Barker RA
    J Neurol; 2005 Jul; 252(7):833-8. PubMed ID: 15772739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers.
    Hilt LM; Sander LC; Nolen-Hoeksema S; Simen AA
    Neurosci Lett; 2007 Dec; 429(1):12-6. PubMed ID: 17959306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of BDNF Val66Met Polymorphism With Trait Anxiety in Panic Disorder.
    Konishi Y; Tanii H; Otowa T; Sasaki T; Kaiya H; Okada M; Okazaki Y
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):344-51. PubMed ID: 26037856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interacting effect of BDNF Val66Met polymorphism and stressful life events on adolescent depression.
    Chen J; Li X; McGue M
    Genes Brain Behav; 2012 Nov; 11(8):958-65. PubMed ID: 22931410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
    Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
    Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
    Hwang JP; Tsai SJ; Hong CJ; Yang CH; Lirng JF; Yang YM
    Neurobiol Aging; 2006 Dec; 27(12):1834-7. PubMed ID: 16343697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.
    Gao L; Díaz-Corrales FJ; Carrillo F; Díaz-Martín J; Caceres-Redondo MT; Carballo M; Palomino A; López-Barneo J; Mir P
    Acta Neurol Scand; 2010 Jul; 122(1):41-5. PubMed ID: 20085561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Altmann V; Schumacher-Schuh AF; Rieck M; Callegari-Jacques SM; Rieder CR; Hutz MH
    Neurosci Lett; 2016 Feb; 615():88-91. PubMed ID: 26806863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease.
    Chen CM; Chen IC; Chang KH; Chen YC; Lyu RK; Liu YT; Hu FJ; Chao CY; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):458-62. PubMed ID: 17427185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents.
    Tocchetto A; Salum GA; Blaya C; Teche S; Isolan L; Bortoluzzi A; Rebelo E Silva R; Becker JA; Bianchin MM; Rohde LA; Leistner-Segal S; Manfro GG
    Neurosci Lett; 2011 Sep; 502(3):197-200. PubMed ID: 21839144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
    Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
    Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.